Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PNC Financial Services
PNC
|
+$630M |
| 2 |
Nike
NKE
|
+$627M |
| 3 |
XYZ
Block Inc
XYZ
|
+$306M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$295M |
| 5 |
FedEx
FDX
|
+$248M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
Meta Platforms (Facebook)
META
|
+$669M |
| 3 |
AbbVie
ABBV
|
+$567M |
| 4 |
Corning
GLW
|
+$343M |
| 5 |
McDonald's
MCD
|
+$342M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.83% |
| 2 | Consumer Discretionary | 16.55% |
| 3 | Financials | 13.82% |
| 4 | Healthcare | 12.55% |
| 5 | Communication Services | 11.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Glaukos
GKOS
$9.83B
| $18.6M | 0.02% |
602,106
+189,187
| +46% | +$5.73M |
|
|
ARMO
402
DELISTED
ARMO BioSciences, Inc. Common Stock
ARMO
| $18.4M | 0.02% |
+493,061
| New | +$20.7M |
|
|
HUD
403
DELISTED
Hudson Ltd. Class A Common Shares
HUD
| $18M | 0.02% |
+1,130,861
| New | +$18.1M |
|
|
EQGP
404
DELISTED
EQGP Holdings, LP
EQGP
| $17.8M | 0.02% |
769,268
-108,496
| -12% | -$2.79M |
|
405
Prestige Consumer Healthcare
PBH
$2.38B
| $17.6M | 0.02% |
523,121
+8,815
| +2% | +$338K |
|
406
Energy Transfer Partners
ET
$70.1B
| $17.6M | 0.02% |
1,239,144
+413,492
| +50% | +$6.87M |
|
407
Core Laboratories
CLB
$488M
| $17.6M | 0.02% |
162,449
-60,246
| -27% | -$6.67M |
|
|
ETP
408
DELISTED
Energy Transfer Partners, L.P.
ETP
| $17.5M | 0.02% |
1,077,089
-46,404
| -4% | -$862K |
|
409
MGP Ingredients
MGPI
$379M
| $17.2M | 0.02% |
192,085
+13,044
| +7% | +$1.06M |
|
|
KA
410
DELISTED
Kineta, Inc. Common Stock
KA
| $17.2M | 0.02% |
25,870
+3,167
| +14% | +$1.91M |
|
|
EQM
411
DELISTED
EQM Midstream Partners, LP
EQM
| $17M | 0.02% |
287,692
-299
| -0.1% | -$20.3K |
|
412
BioCryst Pharmaceuticals
BCRX
$2.28B
| $16.7M | 0.02% |
3,504,595
+422,360
| +14% | +$2.17M |
|
|
TPGH.U
413
DELISTED
TPG Pace Holdings Corp. Units, each consisting of one Class A ordinary share, $.0001 par value, and
TPGH.U
| $16.5M | 0.02% |
1,575,184
-1,767
| -0.1% | -$18.3K |
|
|
AEUA
414
DELISTED
Anadarko Petroleum Corporation
AEUA
| $16.5M | 0.02% |
552,492
+38,855
| +8% | +$1.34M |
|
415
PagSeguro Digital
PAGS
$2.69B
| $16.4M | 0.02% |
+426,677
| New | +$13.7M |
|
|
MRTX
416
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $16.2M | 0.02% |
528,396
+40,797
| +8% | +$1.13M |
|
417
Entergy
ETR
$50.2B
| $16.1M | 0.02% |
+409,838
| New | +$15.8M |
|
418
Pacira BioSciences
PCRX
$1.04B
| $16M | 0.02% |
+515,132
| New | +$18.3M |
|
|
ABMD
419
DELISTED
Abiomed Inc
ABMD
| $16M | 0.02% |
55,032
-68,507
| -55% | -$17.4M |
|
420
Independence Realty Trust
IRT
$3.92B
| $15.9M | 0.02% |
1,728,871
+155,436
| +10% | +$1.41M |
|
421
Idexx Laboratories
IDXX
$44.1B
| $15.8M | 0.02% |
+82,349
| New | +$15.2M |
|
422
Agios Pharmaceuticals
AGIO
$1.79B
| $15.6M | 0.02% |
190,752
+24,497
| +15% | +$1.89M |
|
423
Starbucks
SBUX
$120B
| $15.4M | 0.02% |
265,206
+70,836
| +36% | +$4.09M |
|
|
KYNB
424
Kyntra Bio
KYNB
$27.2M
| $15M | 0.01% |
13,002
+1,925
| +17% | +$2.54M |
|
425
Monolithic Power Systems
MPWR
$70.1B
| $15M | 0.01% |
129,704
-10,347
| -7% | -$1.23M |
|
Similar funds
Jennison Associates's Q1 2018 Portfolio in Review
As of Q1 2018, Jennison Associates held 730 positions worth $101B, down 0.67% from $101B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jennison Associates withdrew a net $4.02B in Q1 2018, closing 79 positions and reducing 339 holdings. Its most notable exit was Newell Brands, an estimated $95.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jennison Associates opened a new position in Emerson Electric worth $113M.
- Jennison Associates's largest Q1 2018 buy was Emerson Electric: 1,658,090 shares worth $113M.
- Jennison Associates added most to PNC Financial Services in Q1 2018, an estimated $630M increase.
- Jennison Associates's biggest Q1 2018 reduction was Apple, cutting an estimated $1.2B.
- Jennison Associates fully exited Newell Brands in Q1 2018, selling an estimated $95.7M.
- Jennison Associates's ten largest holdings make up 28% of its $101B portfolio in Q1 2018.
- Jennison Associates opened 81 new positions and closed 79 in Q1 2018.
- Jennison Associates's portfolio value fell 0.67% quarter-over-quarter to $101B.
Based on Jennison Associates's 13F filing for Q1 2018, filed 20 Apr 2018.